Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10 2023 - 4:05PM
Business Wire
Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company
committed to advancing new medicines for patients with cancer,
today announced the grant of stock options to purchase 28,917
shares of its common stock to five new employees. The awards were
granted pursuant to the Nasdaq inducement grant exception as an
inducement material to the employees’ acceptance of employment with
Verastem Oncology in accordance with Nasdaq Listing Rule
5635(c)(4). The stock options have an exercise price equal to $7.75
per share, the closing price of Verastem Oncology’s common stock as
reported by Nasdaq on July 3, 2023. The stock options that were
granted to the five new employees will vest at a rate of
twenty-five percent (25%) on the one-year anniversary of the
employees’ date of hire, with the remaining shares vesting
quarterly over the next three (3) years in equal quarterly amounts,
provided the employees continue to serve as an employee of or other
service provider to Verastem Oncology on each such vesting
date.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a
development-stage biopharmaceutical company committed to the
development and commercialization of new medicines to improve the
lives of patients diagnosed with cancer. Our pipeline is focused on
novel small molecule drugs that inhibit critical signaling pathways
in cancer that promote cancer cell survival and tumor growth,
including RAF/MEK inhibition and FAK inhibition. For more
information, please visit www.verastem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230710773544/en/
Investors: Dan Calkins Investor Relations +1 781-469-1694
dcalkins@verastem.com
Argot Partners Nate LiaBraaten +1 212-600-1902
nate@argotpartners.com
Media: Lisa Buffington Corporate Communications +1 781-292-4205
lbuffington@verastem.com
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Jul 2024 to Aug 2024
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Aug 2023 to Aug 2024